Lufeng Liang

573 total citations
20 papers, 469 citations indexed

About

Lufeng Liang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Lufeng Liang has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Surgery and 10 papers in Oncology. Recurrent topics in Lufeng Liang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Peptidase Inhibition and Analysis (8 papers) and Ubiquitin and proteasome pathways (5 papers). Lufeng Liang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Peptidase Inhibition and Analysis (8 papers) and Ubiquitin and proteasome pathways (5 papers). Lufeng Liang collaborates with scholars based in China. Lufeng Liang's co-authors include Senlin Chen, Qiong Zou, Zhulin Yang, Jinghe Li, Xiongying Miao, Meigui Chen, Yuan Yuan, Guixiang Zeng, Daiqiang Li and Yuan Yuan and has published in prestigious journals such as Histopathology, Tumor Biology and Cancer Investigation.

In The Last Decade

Lufeng Liang

20 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lufeng Liang China 14 268 130 126 92 72 20 469
Zhihai Peng China 8 476 1.8× 192 1.5× 146 1.2× 48 0.5× 47 0.7× 15 616
Miaofeng Zhang China 9 421 1.6× 144 1.1× 155 1.2× 71 0.8× 30 0.4× 13 613
Jiongqiang Huang China 10 272 1.0× 153 1.2× 116 0.9× 53 0.6× 32 0.4× 15 425
Hye Jeong Oh South Korea 7 156 0.6× 74 0.6× 198 1.6× 43 0.5× 34 0.5× 14 381
Kin‐Fai Cheung Hong Kong 6 267 1.0× 120 0.9× 110 0.9× 63 0.7× 28 0.4× 7 394
Veerabrahma Pratap Seshachalam Singapore 9 430 1.6× 208 1.6× 100 0.8× 36 0.4× 197 2.7× 12 657
Eun‐Kyoung Breuer United States 13 309 1.2× 152 1.2× 181 1.4× 24 0.3× 66 0.9× 17 475
Joan Fernando Spain 7 334 1.2× 128 1.0× 192 1.5× 27 0.3× 56 0.8× 8 532
Junwei Fan China 9 245 0.9× 85 0.7× 103 0.8× 43 0.5× 44 0.6× 15 354
Christopher J. Nelsen United States 11 340 1.3× 86 0.7× 211 1.7× 168 1.8× 104 1.4× 11 640

Countries citing papers authored by Lufeng Liang

Since Specialization
Citations

This map shows the geographic impact of Lufeng Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lufeng Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lufeng Liang more than expected).

Fields of papers citing papers by Lufeng Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lufeng Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lufeng Liang. The network helps show where Lufeng Liang may publish in the future.

Co-authorship network of co-authors of Lufeng Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Lufeng Liang. A scholar is included among the top collaborators of Lufeng Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lufeng Liang. Lufeng Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qunwei, Zhulin Yang, Qiong Zou, et al.. (2016). SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer. Cancer Investigation. 34(6). 255–264. 21 indexed citations
2.
Zhang, Danhua, Zhulin Yang, Enxiang Zhou, et al.. (2016). Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma. Oncology Letters. 12(6). 5136–5144. 31 indexed citations
3.
Liu, Ziru, Zhulin Yang, Qiong Zou, et al.. (2016). MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Molecular Medicine Reports. 14(5). 4581–4592. 13 indexed citations
4.
Yang, Zhulin, Chunwei Wang, Xiongying Miao, et al.. (2016). The Clinicopathological Significance of Jagged1 and DLL4 in Gallbladder Cancer. Tumori Journal. 103(6). 557–565. 7 indexed citations
5.
Liu, Luyao, Zhulin Yang, Chunwei Wang, et al.. (2015). The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance. Pathology & Oncology Research. 22(3). 483–492. 21 indexed citations
6.
Liang, Lufeng, et al.. (2015). LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.. International Journal of Clinical and Experimental Pathology. 8(2). 1690–7. 30 indexed citations
7.
Liu, Ziru, Zhulin Yang, Dong-cai Liu, et al.. (2014). TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Oncology Letters. 7(4). 1128–1138. 19 indexed citations
8.
Yang, Zhulin, Xiongying Miao, Qiong Zou, et al.. (2014). ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. Journal of Molecular Histology. 46(1). 57–65. 24 indexed citations
9.
Ren, Feng, Zhulin Yang, Dong-cai Liu, et al.. (2014). DNA-PKcs and Ku70 are Predictive Markers for Poor Prognosis of Patients With Gall Bladder Malignancies. Applied immunohistochemistry & molecular morphology. 22(10). 741–747. 9 indexed citations
10.
Yi, Shengen, Xiongying Miao, Qiong Zou, et al.. (2014). N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. Pathology - Research and Practice. 210(6). 363–368. 25 indexed citations
11.
Yuan, Yuan, Zhulin Yang, Xiongying Miao, et al.. (2014). EphB1 and Ephrin-B, New Potential Biomarkers for Squamous Cell/adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder. Asian Pacific Journal of Cancer Prevention. 15(3). 1441–1446. 4 indexed citations
12.
Yang, Zhulin, Xiongying Miao, Li Xiong, et al.. (2013). CFL1 and Arp3 are Biomarkers for Metastasis and Poor Prognosis of Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas of Gallbladder. Cancer Investigation. 31(2). 132–139. 46 indexed citations
13.
Li, Jiequn, Qiong Zou, Yuan Yuan, et al.. (2013). Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder: An Immunohistochemistry Study of Prognostic Markers. Pathology & Oncology Research. 20(2). 285–292. 4 indexed citations
14.
Zou, Qiong, Zhulin Yang, Yuan Yuan, et al.. (2013). Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma. World Journal of Surgical Oncology. 11(1). 143–143. 31 indexed citations
15.
Miao, Xiongying, Zhulin Yang, Xiong Li, et al.. (2013). Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.. PubMed. 6(2). 179–90. 67 indexed citations
16.
Yang, Zhulin, Zhi Yang, Qiong Zou, et al.. (2013). A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. International Journal of Clinical Oncology. 19(2). 325–335. 16 indexed citations
17.
Li, Jinghe, Zhulin Yang, Qiong Zou, et al.. (2013). ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder. Journal of Molecular Histology. 45(1). 47–57. 23 indexed citations
18.
Liu, Ziru, Qiong Zou, Yuan Yuan, et al.. (2013). Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas. Histopathology. 64(7). 921–934. 13 indexed citations
19.
Yang, Zhulin, Leping Yang, Qiong Zou, et al.. (2013). Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer. Disease Markers. 35(3). 163–172. 43 indexed citations
20.
Li, Jinghe, Qiong Zou, Yuan Yuan, et al.. (2012). ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Tumor Biology. 34(1). 359–368. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhihai Peng Breakdown of academic impact, for papers by Miaofeng Zhang Breakdown of academic impact, for papers by Jiongqiang Huang Breakdown of academic impact, for papers by Hye Jeong Oh Breakdown of academic impact, for papers by Kin‐Fai Cheung Breakdown of academic impact, for papers by Veerabrahma Pratap Seshachalam Breakdown of academic impact, for papers by Eun‐Kyoung Breuer Breakdown of academic impact, for papers by Joan Fernando Breakdown of academic impact, for papers by Junwei Fan Breakdown of academic impact, for papers by Christopher J. Nelsen
Rankless by CCL
2026